SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-18-001363
Filing Date
2018-03-07
Accepted
2018-03-07 16:11:32
Documents
107
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2234429z10-k.htm 10-K 1652223
2 EX-10.24 a2234429zex-10_24.htm EX-10.24 933765
3 EX-10.25 a2234429zex-10_25.htm EX-10.25 431964
4 EX-10.27 a2234429zex-10_27.htm EX-10.27 144633
5 EX-10.28 a2234429zex-10_28.htm EX-10.28 31294
6 EX-21.1 a2234429zex-21_1.htm EX-21.1 4446
7 EX-23.1 a2234429zex-23_1.htm EX-23.1 2876
8 EX-31.1 a2234429zex-31_1.htm EX-31.1 8887
9 EX-31.2 a2234429zex-31_2.htm EX-31.2 8875
10 EX-32 a2234429zex-32.htm EX-32 7434
17 G11173KM17I001.JPG g11173km17i001.jpg GRAPHIC 1205
18 G11173KO01I001.GIF g11173ko01i001.gif GRAPHIC 1810
19 G821463.JPG g821463.jpg GRAPHIC 49361
  Complete submission text file 0001047469-18-001363.txt   10954935

Data Files

Seq Description Document Type Size
11 EX-101.INS cldx-20171231.xml EX-101.INS 2422836
12 EX-101.SCH cldx-20171231.xsd EX-101.SCH 67346
13 EX-101.CAL cldx-20171231_cal.xml EX-101.CAL 83644
14 EX-101.LAB cldx-20171231_lab.xml EX-101.LAB 629073
15 EX-101.PRE cldx-20171231_pre.xml EX-101.PRE 485159
16 EX-101.DEF cldx-20171231_def.xml EX-101.DEF 254483
Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-15006 | Film No.: 18673480
SIC: 2835 In Vitro & In Vivo Diagnostic Substances